| Patient | Isaac Newton |
|---|---|
| Date of birth | 1976-01-04 |
| Identifiers | MRN HR-EN011-SYN; SSN (made up) 000-11-6840 |
| Document date | 2026-10-08 |
| Author | Rupert Okonkwo-Fairbanks, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Ten-day review of metal and laboratory results; occupational and environmental medicine consultation today. [S]
Mr. Newton returns ten days after his first visit. He has not entered the laboratory since then; the university safety office sealed it four days ago, after measuring mercury vapor, and removed the mercury and arsenic compounds. He has moved out of the rooms next to it. He has kept the sleep diary and a fixed rising time, sleeps about four hours, and has stopped working at night, but still dozes in his chair in the evening. He eats two small meals a day. He met by chance a friend to whom he had written an odd letter and asked him to pass on his apology; he says the ideas that friends were plotting against him now seem to him to have come out of exhaustion, though he still feels slighted by one colleague. He has had no thoughts of death, of harming himself, or of harming anyone. He saw Dr. Mbeki-Lindström of occupational and environmental medicine this morning. [S]
| Element | Detail |
|---|---|
| Exposure | None since intake; laboratory sealed; mercury vapor measured; chemicals removed |
| Sleep | About four hours; no night work; evening dozing continues |
| Appetite and weight | Two small meals a day; 63.8 kg, down 0.2 kg |
| Suspicious ideas | Largely given up; he attributes them to exhaustion and has apologized |
| Safety | No suicidal thoughts and no thoughts of harming others |
| PHQ-9 | 19, down from 20; item 9 scored 0 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Poor appetite; tired; no fever |
| Ears, nose, mouth, and throat | Negative | No bleeding gums, mouth ulcers, metallic taste, or excess salivation |
| Neurological | Negative | No tremor, numbness, tingling, or weakness; handwriting unchanged |
| Genitourinary | Negative | No frothy urine or swelling |
| Psychiatric | Positive | Low mood, loss of interest, poor concentration, early waking; no elevated mood, racing thoughts, or reduced need for sleep with high energy; no hallucinations |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 2026-10-08 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-08 | Body height | 170 | cm | S |
| 2026-10-08 | Body weight | 63.8 | kg | S |
| 2026-10-08 | Body mass index (BMI) [Ratio] | 22.1 | kg/m2 | S |
| 2026-10-08 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-10-08 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-10-08 | Heart rate | 80 | /min | S |
| 2026-10-08 | Respiratory rate | 14 | /min | S |
| 2026-10-08 | Body temperature | 36.6 | Cel | S |
| 2026-10-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-08 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 19 | {score} | S |
Vital signs recorded on 2026-10-08; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Thin, tired, neatly dressed |
| Mouth | Gums pink and firm; no gingivitis, stomatitis, or excess saliva |
| Neurological | No postural or intention tremor of the hands, eyelids, or lips; finger-nose and spiral drawing normal; handwriting steady; normal strength, reflexes, and sensation, including vibration at the toes |
| Mental status | Courteous and engaged; mood "low"; affect constricted; thought process linear; no fixed false beliefs; a residual sense of being slighted by a colleague, held with doubt; no hallucinations; no suicidal or homicidal ideation; insight good |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| A year of poor sleep and poor appetite with 4 kg weight loss, two weeks of near-total sleeplessness, low spirits, and suspicious thoughts that colleagues and friends were plotting against him, now partly doubted; under evaluation for depression, a toxic cause, and other medical causes | resolved | confirmed | R45.89 | S — Synthetic presenting concern echoing the poor sleep, poor appetite, distress, and retracted suspicions documented in his letters of September 1693; superseded by the diagnoses at the second visit. |
| Occupational exposure to elemental and inorganic mercury, with lesser exposure to lead, antimony, and arsenic compounds, from heating metals in an unventilated private laboratory | active | confirmed | Z57.5 | S — Synthetic modern exposure echoing his documented chemical and alchemical work with metals, including mercury; no level of historical exposure is asserted. |
| Major depressive disorder, single episode, severe, without psychotic features (PHQ-9 20 at intake): a year of poor sleep and appetite with weight loss, low mood, poor concentration, and suspicious ideas held with partial insight; medical causes excluded; the contribution of low-level mercury exposure is uncertain | active | confirmed | F32.2 | S — Synthetic modern diagnosis. His sleeplessness, poor appetite, distress, and melancholy in 1693 are documented (D); calling them major depression is a modern reading, and mercury poisoning and other explanations proposed later are disputed (R). |
| Chronic insomnia comorbid with depression: sleep onset and maintenance difficulty for a year, with two weeks of near-total sleeplessness before intake | active | confirmed | G47.00 | S — Synthetic diagnosis echoing his documented sleeplessness. |
| Raised urine mercury from occupational exposure (24-hour urine 46 ug/L, 41 ug/g creatinine; blood 9.4 ug/L) without tremor, gingivitis, erethism, neuropathy, or kidney injury; below the levels linked to overt toxicity | active | confirmed | R82.6 | S — Synthetic result echoing his documented work with mercury; it does not assert that he was poisoned (see CLM-0011, R, disputed). |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PHQ-9 | Baseline, then at least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 19, down from 20; item 9 scored 0 |
| Survey | Suicide and violence risk reassessment (C-SSRS Since Last Visit, PHQ-9 item 9, and thoughts of harming others) | Every visit during active treatment | Completed today | No suicidal thoughts, intent, plan, or behavior; no thoughts of harming others. Protective factors unchanged; the laboratory's toxic chemicals have been removed |
| Laboratory | Workup for medical causes (blood count, metabolic panel, TSH, vitamin B12) | Once, at the initial depression workup | Completed today | Results from the first visit reviewed today: all normal |
| Survey | Bipolar screen at the initial workup | Once, at the initial depression workup | Completed today | No past manic or hypomanic episode on interview today; no Mood Disorder Questionnaire score is recorded |
| Laboratory | 24-hour urine mercury with creatinine correction, and blood mercury | At the exposure assessment, then 4 to 6 weeks after removal and at 3 months | Completed today | Results from the first visit reviewed today: urine 46 ug/L and 41 ug/g creatinine, blood 9.4 ug/L, all raised; blood lead 2.4 ug/dL, normal; repeat in about three weeks |
| Laboratory | Kidney function and urine protein (creatinine, eGFR, urine albumin-to-creatinine ratio) | At the exposure assessment and at 3 months | Completed today | Results from the first visit reviewed today: creatinine 0.92 mg/dL, eGFR 101, ratio 9 mg/g; dipstick protein negative |
| Examination | Signs of mercury toxicity: tremor (postural and intention), handwriting, gums and mouth, erethism, peripheral neuropathy | At the exposure assessment and at each follow-up while levels are raised | Completed today | No tremor, gingivitis, stomatitis, or neuropathy; no erethism beyond what his depression explains |
| Self-management | Removal from exposure and workplace hazard assessment | At once, then until the workplace is safe | Completed today | Laboratory sealed; mercury vapor 0.08 mg/m3 at the furnace (NIOSH limit 0.05 mg/m3 averaged over a shift; OSHA 0.1 mg/m3); chemicals removed; decontamination and a fume hood ordered |
| Medication safety | Chelation and provoked (chelator-challenge) urine testing | Only for symptomatic patients with high levels, decided with a medical toxicologist | Not indicated | Urine mercury below 100 ug/L with no tremor, gingivitis, or kidney injury; removal from exposure comes first, and provoked testing is not valid |
| Medication safety | SSRI tolerability check two weeks after starting | 2 weeks after starting and after each dose change | Due | Sertraline starts today |
| Referral | Occupational and environmental medicine (medical toxicology) consultation | For raised urine mercury with neuropsychiatric symptoms | Completed today | Seen today; chelation not indicated; return-to-work conditions set |
| Examination | Weight and nutrition | Every visit while weight is below his usual | Completed today | 63.8 kg, down 0.2 kg; two small meals a day |
| Self-management | Psychotherapy, sleep, and activity | Every visit during active treatment | Completed today | CBT booked; CBT-I sleep window set; walks most days |
| Laboratory | Lithium, anticonvulsant, or antipsychotic monitoring (levels, metabolic tests, AIMS) | Only on those drugs | Not indicated | Treated with an SSRI only; no antipsychotic, because there are no psychotic features |
Goal progress:
Guideline basis: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) (2022); Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016); Evaluating Mercury Exposure: Information for Health Care Providers (2018); NIOSH Pocket Guide to Chemical Hazards: Mercury compounds [except (organo) alkyls] (as Hg) (2026); American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing (2010); Use and Misuse of Metal Chelation Therapy (McKay CA, editorial) and Recommendations for Provoked Challenge Urine Testing (Ruha AM), proceedings of the ACMT symposium (2013)
Follow-up: Depression and exposure review in three weeks with a repeat 24-hour urine mercury; telephone contact sooner if needed. Next scheduled visit 2026-10-22: preventive health visit at 50. [S]